Physician profile
Lisa M Pullen
NPI 1871672717
$4,174.29
in general payments reported to CMS, 2019-2025
17 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what 81% of Psychiatric/Mental Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $244).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $536 · 2022: $431 · 2023: $974 · 2024: $1,045 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,207.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $976.01 | 2021-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Janssen Pharmaceuticals, INC | $643.24 | 2022-2025 | Spravato |
| Vanda Pharmaceuticals INC. | $537.44 | 2024-2025 | Fanapt, Hetlioz |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $507.29 | 2021-2025 | Caplyta |
| Abbvie INC. | $322.69 | 2021-2025 | |
| Axsome Therapeutics, INC. | $320.16 | 2023-2025 | Auvelity |
| Myriad Genetic Laboratories, INC. | $264.00 | 2023 | Myrisk |
| Harmony Biosciences LLC | $106.80 | 2024 | |
| Alkermes, INC. | $102.85 | 2021-2023 | Lybalvi |
| Neurocrine Biosciences, INC. | $91.74 | 2021-2025 | Ingrezza |
| Lundbeck LLC | $90.46 | 2021-2024 | Rexulti |
| Bausch Health US, LLC | $85.87 | 2021-2024 | Aplenzin |
| Takeda Pharmaceuticals U.S.A., INC. | $43.18 | 2021 | |
| Corium, LLC | $27.94 | 2024 | Azstarys |
| Adlon Therapeutics L.P. | $23.38 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $18.24 | 2022 | |
| Almatica Pharma LLC | $13.00 | 2023 | Sertraline Hcl, Loreev Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Pullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.